ALK and medullary thyroid gland carcinoma: In the current study, the MTC case harboring the GFPT1-ALK fusion showed strong ALK protein expression and did not exhibit co-existing genetic mutations; both of these factors may support an important role for this fusion gene in the pathogenesis of this MTC case.